Biotechnology - Companies & Stock Screener

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%

Market Cap

P/E Ratio

YoY Change

Veradermics, Incorporated

MANE

Market Cap $3.92B

Dividends 0.0%

P/E Ratio -64.0

Revenue $0.00

Net Income -$27.2M

Profit Margin

Employees 21

View Stock

ARCA biopharma Inc

ABIO

Market Cap $2.71B

Dividends 0.0%

P/E Ratio -34.3

Revenue $0.00

Net Income -$31.8M +51.5%

Profit Margin

Employees 28

View Stock

Oruka Therapeutics, Inc.

ORKA

Market Cap $2.71B

Dividends 0.0%

P/E Ratio -34.3

Revenue $0.00

Net Income -$31.8M +51.5%

Profit Margin

Employees 28

View Stock

Mind Medicine Inc

MNMD

Market Cap $2.67B

Dividends 0.0%

P/E Ratio -9.8

Revenue $0.00

Net Income -$77.1M +230.2%

Profit Margin

Employees 74

View Stock

Definium Therapeutics, Inc.

DFTX

Market Cap $2.67B

Dividends 0.0%

P/E Ratio -9.8

Revenue $0.00

Net Income -$77.1M +230.2%

Profit Margin

Employees 74

View Stock

Septerna, Inc.

SEPN

Market Cap $1.63B

Dividends 0.0%

P/E Ratio -44.9

Revenue $26.5M +12011.0%

Net Income -$8.64M -59.8%

Profit Margin -32.6%

Employees 75

View Stock

MBX Biosciences, Inc. Common Stock

MBX

Market Cap $1.45B

Dividends 0.0%

P/E Ratio -23.1

Revenue $0.00

Net Income -$23.5M -1.5%

Profit Margin

Employees 43

View Stock

Pieris Pharmaceuticals Inc

PIRS

Market Cap $1.34B

Dividends 0.0%

P/E Ratio -3.6

Revenue $0.00

Net Income -$15.8M +92.6%

Profit Margin

Employees 14

View Stock

Palvella Therapeutics, Inc.

PVLA

Market Cap $1.34B

Dividends 0.0%

P/E Ratio -30.0

Revenue $0.00

Net Income -$15.8M +92.6%

Profit Margin

Employees 14

View Stock

Bicara Therapeutics Inc. Common Stock

BCAX

Market Cap $1.27B

Dividends 0.0%

P/E Ratio -8.4

Revenue $0.00

Net Income -$56.2M +52.6%

Profit Margin

Employees 55

View Stock

Zenas BioPharma, Inc.

ZBIO

Market Cap $883.04M

Dividends 0.0%

P/E Ratio -2.6

Revenue $0.00 -100.0%

Net Income -$81M +141.2%

Profit Margin

Employees 130

View Stock

LB Pharmaceuticals Inc Common Stock

LBRX

Market Cap $860.3M

Dividends 0.0%

P/E Ratio -1.4

Revenue $0.00

Net Income -$19.1M

Profit Margin

Employees 16

View Stock

Ikena Oncology Inc

IKNA

Market Cap $718.82M

Dividends 0.0%

P/E Ratio -1.5

Revenue $0.00

Net Income -$10.6M +23.2%

Profit Margin

Employees 10

View Stock

ImageneBio Inc

IMA

Market Cap $718.82M

Dividends 0.0%

P/E Ratio -1.5

Revenue $0.00

Net Income -$10.6M +23.2%

Profit Margin

Employees 10

View Stock

SpyGlass Pharma, Inc. Common Stock

SGP

Market Cap $625.2M

Dividends 0.0%

P/E Ratio -14.1

Revenue $0.00

Net Income -$13.8M

Profit Margin

Employees 1.49K

View Stock

Aerovate Therapeutics Inc

AVTE

Market Cap $548.77M

Dividends 0.0%

P/E Ratio -7.5

Revenue $0.00

Net Income -$40.4M +1503.2%

Profit Margin

Employees 50

View Stock

Jade Biosciences, Inc.

JBIO

Market Cap $548.77M

Dividends 0.0%

P/E Ratio -7.5

Revenue $0.00

Net Income -$40.4M +1503.2%

Profit Margin

Employees 50

View Stock

AgomAb Therapeutics N.V. American Depositary Shares

AGMB

Market Cap $540.74M

Dividends 0.0%

P/E Ratio -7.5

Revenue $0.00

Net Income -$11.7M

Profit Margin

Employees 57

View Stock

Tribe Capital Growth Corp I - Units (1 Ord Share Class A & 1/4 War)

ATVCU

Market Cap $338.44M

Dividends 0.0%

P/E Ratio 0.0

Revenue $0.00

Net Income -$643k

Profit Margin

Employees 4

View Stock

Tribe Capital Growth Corp I - Class A

ATVC

Market Cap $338.44M

Dividends 0.0%

P/E Ratio 0.0

Revenue $0.00

Net Income -$643k

Profit Margin

Employees 4

View Stock

Stock Screener

Veradermics, Incorporated

Veradermics, Incorporated

ARCA biopharma Inc

ARCA biopharma Inc

Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc.

Mind Medicine Inc

Mind Medicine Inc

Definium Therapeutics, Inc.

Definium Therapeutics, Inc.

Septerna, Inc.

Septerna, Inc.

MBX Biosciences, Inc. Common Stock

MBX Biosciences, Inc. Common Stock

Pieris Pharmaceuticals Inc

Pieris Pharmaceuticals Inc

Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

Bicara Therapeutics Inc. Common Stock

Bicara Therapeutics Inc. Common Stock

Zenas BioPharma, Inc.

Zenas BioPharma, Inc.

LB Pharmaceuticals Inc Common Stock

LB Pharmaceuticals Inc Common Stock

Ikena Oncology Inc

Ikena Oncology Inc

ImageneBio Inc

ImageneBio Inc

SpyGlass Pharma, Inc. Common Stock

SpyGlass Pharma, Inc. Common Stock

Aerovate Therapeutics Inc

Aerovate Therapeutics Inc

Jade Biosciences, Inc.

Jade Biosciences, Inc.

AgomAb Therapeutics N.V. American Depositary Shares

AgomAb Therapeutics N.V. American Depositary Shares

Tribe Capital Growth Corp I - Units (1 Ord Share Class A & 1/4 War)

Tribe Capital Growth Corp I - Units (1 Ord Share Class A & 1/4 War)

Tribe Capital Growth Corp I - Class A

Tribe Capital Growth Corp I - Class A

Cookie Settings